ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "autoantibodies and rheumatoid arthritis (RA)"

  • Abstract Number: 14 • 2018 ACR/ARHP Annual Meeting

    Individual RA-Derived Monoclonal Anti-Citrullinated Protein Autoantibodies (ACPA) Have Extensive Citrulline Multi-Reactivity Demonstrated By a Large-Scale Protein Array Platform

    Peter Sahlström1, Johanna Steen1, Madeleine Jenning2, Philip J. Titcombe1,3, Ute Nonhoff4,5, Ragnhild Stålesen6, Bianka Marklein2, Daniel L. Mueller3, Zoltan Konthur4, Karin Lundberg7, Anca I. Catrina6, Lars Klareskog1, Vivianne Malmström1, Karl Skriner2 and Caroline Grönwall8, 1Rheumatology Unit, Dept. of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Dept. of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 3The Center for Immunology, Dept. of Medicine, University of Minnesota Medical School, Minneapolis, MN, 4Engine GmbH, Hennigsdorf, Germany, 5Max Planck Institute of Colloids and Interfaces, Potsdam, Germany, 6Rheumatology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 7Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 8Dep. of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: The presence of serum IgG anti-citrullinated protein autoantibodies (ACPA) in rheumatoid arthritis (RA), is associated with more aggressive disease progression. Although ACPA have been…
  • Abstract Number: 77 • 2018 ACR/ARHP Annual Meeting

    Single Nucleotide Polymorphism in the Gene Encoding Peptidylarginine Deiminase 4 Correlates with Reduced Neutrophil Extracellular Traps and Anti-Histone Antibodies in Rheumatoid Arthritis

    Aisha M. Mergaert1, Mandar Bawadekar2, Thai Q. Nguyen1, Steven J. Schrodi3,4 and Miriam A. Shelef2,5, 1University of Wisconsin - Madison, Madison, WI, 2Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, Madison, WI, 3Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, 4Computation and Informatics in Biology and Medicine, University of Wisconsin - Madison, Madison, WI, 5William S. Middleton Memorial Veterans Hospital, Madison, WI

    Background/Purpose: In neutrophils, peptidylarginine deiminase 4 (PAD4) citrullinates histones allowing chromatin unraveling and neutrophil extracellular trap (NET) formation. NETs are increased and display proteins targeted…
  • Abstract Number: 79 • 2018 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis (RA)-Associated Autoantibodies Are Present in the Periodontal Exudate of Patients with and without RA

    Poerwati Soetji Rahajoe1, Menke J. de Smit2, Elisabeth Eelsing2, Nyoman Kertia3, Arjan Vissink4 and Johanna Westra2, 1Oral Surgery, Dr. Sardjito General Hospital, Yogyakarta, Indonesia, 2Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology, Dr. Sardjito General Hospital, Yogyakarta, Indonesia, 4Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Seropositivity for anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) is a hallmark of RA and can be present years before clinical onset has…
  • Abstract Number: 554 • 2018 ACR/ARHP Annual Meeting

    Are There Any Associations between ANA Development and Poor Treatment Response to Bdmards in RA Patients?

    Yuki Ishikawa1, Motomu Hashimoto2, Hiromu Ito3, Masao Tanaka2, Naoichiro Yukawa4, Takao Fujii5, Wataru Yamamoto6, Tsuneyo Mimori7 and Chikashi Terao8,9,10, 1One Joslin Place, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 2Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 4Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Wakayama University, Wakayama, Japan, 5Dept of Rheum/Clinical Immun, Wakayama Medical University, Wakayama, Japan, 6Department of Health Information Management, Kurashiki Sweet Hospital, Okayama, Japan, 7Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 8Center for Investigative Medical Sciences, RIKEN, Yokohama, Japan, 9Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan, 10Department of Applied Genetics, The School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

    Background/Purpose: It has been well known that anti-TNF-α treatment for RA patients is associated with ANA development. We previously reported that ANA development along with…
  • Abstract Number: 1441 • 2018 ACR/ARHP Annual Meeting

    Diagnostic Performances of Antibodies Against Carbamylated Proteins in US Based Populations with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases

    Jing Shi1, Jay Milo2, Kelley Bradey1, Chelsea Bentow2, John Conklin1, Tyler O'Malley1, Armida Sace1, Rowena Lafon1, Duncan Poling1, Claudia Ibarra1, Michael Mahler2 and Thierry Dervieux1, 1Exagen Diagnostics, Inc., Vista, CA, 2Research and Development, Inova Diagnostics, San Diego, CA

    Background/Purpose: Recently, antibodies directed against carbamylated antigens (anti-CarP antibodies) were identified in rheumatoid arthritis (RA). Studies have established the predictive and prognostic value of this…
  • Abstract Number: 393 • 2017 ACR/ARHP Annual Meeting

    The Role of Follicular Helper 17 T Cells in Glucose-6-Phosphate Isomerase Induced Arthritis

    Izumi Kurata, Isao Matsumoto, Atsumu Osada, Hiroshi Ebe, Hoshimi Kawaguchi, Yuya Kondo, Hiroto Tsuboi and Takayuki Sumida, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: Follicular helper T (Tfh) cell is a novel T cell subset which promotes follicular B cell activation, differentiation to plasma cell and antibody production.…
  • Abstract Number: 1363 • 2017 ACR/ARHP Annual Meeting

    Disease Duration and Shared Epitope, but Not Smoking History, Are Associated with Peptidylarginine Deiminase 4-Antibody Development in Rheumatoid Arthritis

    Laura Cappelli1, Maximilian Konig1, Pooja Naik2, Arvin Saleh3, Allan C. Gelber3, Clifton O. Bingham III4 and Erika Darrah5, 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4Rheumatology, Johns Hopkins University, Baltimore, MD, 5Department of Medicine/Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Clinical characteristics and biomarkers help clinicians predict disease features in rheumatoid arthritis (RA). Both peptidylarginine deiminase 4 (PAD4) antibodies and smoking have been associated…
  • Abstract Number: 1402 • 2017 ACR/ARHP Annual Meeting

    In RA, Becoming Seronegative over the 1st Year of DMARD Treatment Does Not Improve Chances of Drug-Free Remission in the Long-Term

    Emma de Moel1, Veerle Derksen1, LA Trouw1, Holger Bang2, Yvonne P. Goekoop-Ruiterman3, GM Steup-Beekman1,4, Tom W.J. Huizinga5, Cornelia F Allaart5, Rene E.M. Toes1 and Diane van der Woude6, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Orgentec Diagnostika GmbH, Mainz, Germany, 3Rheumatology, HAGA hospital, The Hague, Netherlands, 4Rheumatology, Haaglanden Medical Center, The Hague, Netherlands, 5Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Patients with RA harbor autoantibodies of various isotypes and directed against several post-translational modifications. Baseline seropositivity is a poor prognostic factor for sustained drug-free…
  • Abstract Number: 1971 • 2017 ACR/ARHP Annual Meeting

    Association between Genetic Variants and the Presence of Rheumatoid Arthritis-Related Autoimmunity and Progression to Classified Rheumatoid Arthritis in an at-Risk Population

    Rachael Sawaya1, Elizabeth A. Bemis1, Ryan W. Gan2, Jill M. Norris3, Jeffrey A. Sparks4, Elizabeth Karlson5, M. Kristen Demoruelle6, Kevin D. Deane7, V. Michael Holers8, Marie L. Feser7, Laurie Moss7, Jane H. Buckner9, Richard M. Keating10, Peter Gregersen11, Michael Weisman12, Ted R. Mikuls13 and James R. O'Dell14, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Colorado School of Public Health, University of Colorado Denver, Aurora, CO, 3Department of Epidemiology, Colorado School of Public Health, Aurora, CO, 4Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 61775 Aurora Ct, 1775 Aurora Ct, Aurora, CO, 7Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 8Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, 9Benaroya Research Institute at Virginia Mason, Seattle, WA, 10Division of Rheumatology, Scripps Clinic, La Jolla, CA, 11The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 12Cedars-Sinai Medical Center Division of Rheumatology, Los Angeles, CA, 13Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 14Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by the presence of RA-related autoantibodies prior to the development of clinical disease. While HLA-shared epitope…
  • Abstract Number: 2916 • 2017 ACR/ARHP Annual Meeting

    The Presence of a Large Number of Autoantibodies at Baseline Is Favourable for Early Treatment Response but Unfavourable for Drug-Free Remission in RA Patients

    Emma de Moel1, Veerle Derksen1, LA Trouw1, Holger Bang2, R.J. Goekoop3, I Speyer4, TWJ Huizinga1, CF Allaart1, REM Toes1 and Diane van der Woude5, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Orgentec Diagnostika GmbH, Mainz, Germany, 3Haga Hospital, The Hague, Netherlands, 4Haaglanden Medical Center, The Hague, Netherlands, 5Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The autoantibody response of seropositive RA is very diverse and consists of various numbers of isotypes and antibodies to multiple post-translational modifications. It is…
  • Abstract Number: 2113 • 2016 ACR/ARHP Annual Meeting

    Anti-Carbamylated Protein Antibody (cross)-Reactivity Against Multiple Carbamylated Protein Antigens

    Marije K. Verheul1, Myrthe van Delft2, Tom WJ Huizinga1, REM Toes1 and LA Trouw1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose:   Antibodies that target carbamylated proteins (anti-CarP) have been implicated in rheumatoid arthritis and are known to associate with joint damage. Furthermore, these autoantibodies…
  • Abstract Number: 3103 • 2015 ACR/ARHP Annual Meeting

    Carbamylated Human Albumin Is One of the Target Antigens of Anti-Carbamylated Protein Antibodies

    Shuichiro Nakabo1, Koichiro Ohmura1, Kosaku Murakami1, Ran Nakashima1, Moritoshi Furu2, Masahiro Ishikawa2, Motomu Hashimoto2, Yoshitaka Imura1, Naoichiro Yukawa1, Hajime Yoshifuji1, Hiromu Ito2, Takao Fujii2 and Tsuneyo Mimori1,2, 1Department of Rheumatology and Clinical Immunology, Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2Department of the Control for Rheumatic Diseases, Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Background/Purpose: Anti-carbamylated protein antibody (anti-CarP) is seen in 45% of rheumatoid arthritis (RA) patients [1]. The precise target antigen (Ag) of anti-CarP had not been…
  • Abstract Number: 3154 • 2015 ACR/ARHP Annual Meeting

    The Importance of Somatic Hypermutation for the Immunoreactivity Towards Neutrophil Extracellular Traps (NETs)-Citrullinated Autoantigens of RA Synovial Monoclonal Antibodies

    Elisa Corsiero1, Emanuela Carlotti2, Costantino Pitzalis3 and Michele Bombardieri4, 1WHRI - EMR, London, United Kingdom, 2Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, QMUL, London, United Kingdom, 3Centre for Experimental Medicine & Rheumatology, Queen Mary's School of Medicine and Dentistry, London, United Kingdom, 4Experimental Medicine and Rheumatology, Queen Mary University of London, London, United Kingdom

    Background/Purpose: We previously showed that anti-citrullinated peptide/protein antibodies (ACPA) targeting citrullinated antigens contained in neutrophils extracellular traps (NETs) can be manufactured within ectopic germinal center-like…
  • Abstract Number: 550 • 2015 ACR/ARHP Annual Meeting

    Can Anti-TNF-Induced Autoantibody Conversion be Reversed By Switching to Abatacept Therapy in Patients with RA on Background MTX?

    Maya H. Buch1, A Johnsen2, DA Wong2 and M Schiff3, 1University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 2Bristol-Myers Squibb, Princeton, NJ, 3University of Colorado, Denver, CO

    Background/Purpose: Anti-TNF therapy for RA is associated with antinuclear (ANAs) and anti-double-stranded DNA (anti-dsDNA) autoantibodies.1,2  The effect of biologics on autoantibody-positive patients is unknown. We…
  • Abstract Number: 578 • 2015 ACR/ARHP Annual Meeting

    Study of the Production of Antinuclear Antibodies and Anti-Ds DNA Antibodies in Rheumatoid Arthritis Patients Treated with TNF Inhibitors

    Ran Matsudaira1,2, Naoto Tamura3, Yoshichika Sugisaki2, Tomoko Ito4, Kentaro Minowa2, Michihiro Ogasawara2, Ken Yamaji2, Yoshinori Kanai1, Kenjiro Yamanaka1 and Yoshinari Takasaki2, 1Division of Internal Medicine and Rheumatology, Sasaki institute Kyoundo Hospital, Tokyo, Japan, 2Department of Internal Medicine and Rheumatology, Juntendo University, School of Medicine, Tokyo, Japan, 3Department of Internal Medicien and Rheumatology, Juntendo University, School of Medicine, Tokyo, Japan, 4Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan

    Background/Purpose: The production of autoantibodies, such as anti-nuclear antibodies (ANA) and anti-ds DNA antibodies (anti-DNA), is commonly observed in patients who have been treated with…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology